TH151329A - Pyrimidenone is a PI3K inhibitor. - Google Patents
Pyrimidenone is a PI3K inhibitor.Info
- Publication number
- TH151329A TH151329A TH1101003839A TH1101003839A TH151329A TH 151329 A TH151329 A TH 151329A TH 1101003839 A TH1101003839 A TH 1101003839A TH 1101003839 A TH1101003839 A TH 1101003839A TH 151329 A TH151329 A TH 151329A
- Authority
- TH
- Thailand
- Prior art keywords
- pi3k
- pyrimidenone
- diseases
- activity
- pi3k inhibitor
- Prior art date
Links
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 title 1
- 108040005185 1-phosphatidylinositol-3-kinase activity proteins Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000005343 heterocyclic alkyl group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract 6
- 206010027665 Immune disorder Diseases 0.000 abstract 2
- 206010021425 Immune system disease Diseases 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drugs Drugs 0.000 abstract 1
Abstract
DC60 (23/12/54) การประดิษฐ์นี้ให้ไพริมิดิโนนชนิดต่างๆ ซึ่งปรับเปลี่ยนฤทธิ์ของฟอสฟออิโนซิไทด์ 3- ไคเนส (PI3K) ชนิดต่างๆ และเป็นประโยชน์ในการรักษาโรคต่างๆ ที่เกี่ยวข้องกับฤทธิ์ของ PI3K ซึ่งประกอบด้วย ยกตัวอย่างเช่น ความผิดปกติที่เกิดจากการอักเสบ ความผิดปกติทางภูมิคุ้มกัน มะเร็ง และโรคอื่นๆ การประดิษฐ์นี้ให้ไพริมิดิโนนชนิดต่างๆ ซึ่งปรับเปลี่ยนฤทธิ์ของฟอสฟออิโนซิไทด์3- ไคเนส(PI3K)ชนิดต่างๆและเป็นประโยชน์ในการรักษาโรคต่างๆที่เกี่ยวข้องกับฤทธิ์ของ PI3K ซึ่งประกอบด้วย ยกตัวอย่างเช่น ความผิดปกติที่เกิดจากการอักเสบ ความผิดปกติทางภูมิคุ้มกัน มะเร็ง และโรคอื่นๆ สิทธิบัตรยา DC60 (23/12/54) This invention gives different types of pyrimidenone. Which modifies the activity of various types of phosphoinoside 3-kinase (PI3K) and is useful in the treatment of various diseases. Related to the activity of PI3K, which includes For example Disorders caused by inflammation Immune disorders, cancer and other diseases. This invention provides different types of pyrimidenone. Which modifies the activity of various types of phosphoocytide 3-kinase (PI3K) and is useful in the treatment of diseases related to PI3K activity including For example Disorders caused by inflammation Immune disorders, cancer and other diseases, patent drug
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH151329A true TH151329A (en) | 2016-05-19 |
| TH1101003839B TH1101003839B (en) | 2016-05-19 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201905814T4 (en) | Biprazole salt as a jack inhibitor. | |
| MD4666B1 (en) | Syk inhibitors | |
| EA201690094A1 (en) | SYK INHIBITORS | |
| EA201590224A1 (en) | IMIDAZOTRIASINCARBONITRILE USED AS KINASE INHIBITORS | |
| MX338114B (en) | Inhibitors of arginase and their therapeutic applications. | |
| EA201391029A1 (en) | OXAZIN DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF NEUROLOGICAL DISORDERS | |
| EA201300684A1 (en) | DERIVATIVES OF 6-AMINO-2-PHENYLAMINO-1H-BENZIMIDAZOLE-5-CARBOXAMIDE AND THEIR APPLICATION AS AN INHIBITORS OF MICROSOMIC PROSTAGLANDIN-E2-SYNTHASE-1 | |
| EA201492023A1 (en) | REGULATORS OF THE COMPLEX WAY AND THEIR APPLICATION | |
| EA201390917A1 (en) | DIGETEROARYLIC CONNECTIONS AS VPS34 INHIBITORS | |
| EA201592255A1 (en) | DERIVATIVES OF PYRAZOLOPIRROLIDIN-4-IT AS A BET INHIBITOR AND THEIR APPLICATION IN THE TREATMENT OF THE DISEASE | |
| UY30282A1 (en) | CHEMICAL COMPOUNDS | |
| MY161001A (en) | Tetrahydrocarboline Derivative | |
| EA201792597A2 (en) | GLUTARIMIDES DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHODS OF THEIR PRODUCTION | |
| BR112017016817A2 (en) | heterocyclic derivatives formulated as fgfr4 inhibitors | |
| EA201490630A1 (en) | 6-SUBSTITUTED 3- (QUINOLIN-6-ILTIO) [1,2,4] TRIAZOLO [4,3-A] Pyridine as inhibitors of C-MET THYROZINKINASE | |
| BR112014012459A2 (en) | 2h-indazoles as ep2 receptor antagonists | |
| EA201691058A1 (en) | DERIVATIVES OF PYRROLOPIRROLON AND THEIR APPLICATION FOR THE TREATMENT OF DISEASES | |
| UY31812A (en) | CINOLINE DERIVATIVES AS CSF-1 INHIBITORS | |
| TH151329A (en) | Pyrimidenone is a PI3K inhibitor. | |
| BR112015017678A2 (en) | new pyrimidine derivatives as phosphodiesterase 10 inhibitors (pde-10) | |
| TH1401001105A (en) | Heterocyclic amines are PI3K inhibitors. | |
| CU20140021A7 (en) | DERIVATIVES OF 2- AMINO-4- (PIRIDIN-2-IL) -5,6- DIHIDRO-4H-1,3- OXACINE AND ITS USE AS BACE -1 AND / OR BACE-2 INHIBITORS | |
| TH148833B (en) | The imidazo derivative [1,2-b] piridazine is a kinase inhibitor. | |
| TH152683A (en) | Triacine compounds as PI3K and MTOR inhibitors | |
| TR201901937T4 (en) | 8-methyl-1-phenyl-imidazole [1,5-a] pyrazine compounds. |